These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 434726)

  • 1. [Oestrogen therapy of osteoporosis (author's transl)].
    Courrèges JP; Merceron RE; Raymond JP; Klotz HP
    Ann Med Interne (Paris); 1979; 130(3):153-7. PubMed ID: 434726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Post-menopausal osteoporosis : physiopathology and therapy (author's transl)].
    Degueldre-Plisson F
    Sem Hop; 1980 Sep 18-25; 56(33-36):1357-67. PubMed ID: 6252627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium, estrogen, and progestin in the treatment of osteoporosis.
    Breslau NA
    Rheum Dis Clin North Am; 1994 Aug; 20(3):691-716. PubMed ID: 7984785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic concepts in the treatment of postmenopausal osteoporosis].
    Leidig-Bruckner G; Ziegler R
    Ther Umsch; 1994 Nov; 51(11):737-47. PubMed ID: 7839332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does calcium potentiate the effect of estrogen therapy on postmenopausal bone loss?
    Riis BJ; Nilas L; Christiansen C
    Bone Miner; 1987 Feb; 2(1):1-9. PubMed ID: 3504720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sex hormone replacement following menopause--for all women? A plea for prevention using estrogens and gestagens].
    Nocke W
    Ther Umsch; 1995 Oct; 52(10):693-704. PubMed ID: 7482382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
    Josse RG
    CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New approaches to the problems of osteoporosis.
    Nordin BE; Need AG; Morris HA; Horowitz M
    Clin Orthop Relat Res; 1985 Nov; (200):181-97. PubMed ID: 3905110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical use of progestins in the menopausal patient: dosage and duration.
    Gambrell RD
    J Reprod Med; 1982 Aug; 27(8 Suppl):531-8. PubMed ID: 7131446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of patients with postmenopausal osteoporosis and steroid-induced osteoporosis with the preparation Rocaltrol (1,25/OH/2 vitamin D3)].
    Koev D; Todorova S; Diankov L; Khristova D; Tsachev K
    Vutr Boles; 1988; 27(2):117-22. PubMed ID: 3414094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diphosphonates: and alternative to estrogen therapy in postmenopausal osteoporosis. Experience with alendronate].
    Buffo L; Rossini M; Buoncristiano A; Girardello S; Zamberlan N; Diani F; Adami S
    Minerva Ginecol; 1996 Jun; 48(6):263-72. PubMed ID: 8927288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
    Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
    Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis and management of primary osteoporosis.
    Bauwens SF; Drinka PJ; Boh LE
    Clin Pharm; 1986 Aug; 5(8):639-59. PubMed ID: 3527528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical effects of calcium supplementation in postmenopausal osteoporosis.
    Horowitz M; Need AG; Morris HA; Wishart J; Nordin BE
    Eur J Clin Nutr; 1988 Sep; 42(9):775-8. PubMed ID: 3181110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Selective estrogen receptor modulators (SERM): new substances for hormone replacement therapy].
    Burckhardt P
    Schweiz Med Wochenschr; 1999 Dec; 129(49):1926-30. PubMed ID: 10635085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal osteoporosis: the role of estrogens.
    Diddle AW; Smith IQ
    South Med J; 1984 Jul; 77(7):868-74. PubMed ID: 6377508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologic and pharmacologic effects of estrogen and progestins on bone.
    DeCherney A
    J Reprod Med; 1993 Dec; 38(12 Suppl):1007-14. PubMed ID: 8120857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
    Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
    Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and treatment of postmenopausal women at risk for the development of osteoporosis.
    Dören M; Schneider HP
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):431-3. PubMed ID: 1490769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.